Unbiased identification of risk factors for invasive Escherichia coli disease using machine learning

Autor: Erik Clarke, Christel Chehoud, Najat Khan, Bart Spiessens, Jan Poolman, Jeroen Geurtsen

Publikováno v: BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-12 (2024)

Abstract Background Invasive Escherichia coli disease (IED), also known as invasive extraintestinal pathogenic E. coli disease, is a leading cause of sepsis and bacteremia in older adults that can result in hospitalization and sometimes death and is

Externí odkaz: https://doaj.org/article/50776956b4494481bdf02d390acf2d19

Impact of Invasive Escherichia Coli Disease on Clinical Outcomes and Medical Resource Utilization Among Asian Patients in the United States.

Autor: Zhuo, Chao¹ (AUTHOR), Zheng, Bo² (AUTHOR), Wattanakamolkul, Kittima³ (AUTHOR), Nakayama, Yoshikazu³ (AUTHOR), Cloutier, Martin⁴ (AUTHOR), Gauthier-Loiselle, Marjolaine⁴ (AUTHOR) Marjolaine.Gauthier-Loiselle@analysisgroup.com, Feng, Jun⁵ (AUTHOR), Wu, David^5,6 (AUTHOR), Neary, Maureen P.⁷ (AUTHOR), Geurtsen, Jeroen⁸ (AUTHOR), El Khoury, Antoine C.⁷ (AUTHOR), Gu, Yoshiaki⁹ (AUTHOR)

Publikováno v: Infectious Diseases & Therapy. Feb2024, Vol. 13 Issue 2, p313-328. 16p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Epidemiology of invasive Escherichia coli disease in adults in England, 2013-2017.

Autor: Blum M; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Geurtsen J; Bacterial Vaccines Discovery and Early Development, Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Herweijer E; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Sarnecki M; Janssen Vaccines, Bern, Switzerland., Spiessens B; Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica, Beerse, Belgium., Reynolds Diogo G; Janssen Cilag, High Wycombe, UK., Hermans P; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., Thelwall S; UK Health Security Agency, London, UK., Bhattacharya A; UK Health Security Agency, London, UK., Verstraeten T; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Poolman J; Bacterial Vaccines Discovery and Early Development, Janssen Vaccines and Prevention B.V., Leiden, Netherlands., Hope R; UK Health Security Agency, London, UK.

Publikováno v: Epidemiology and infection [Epidemiol Infect] 2025 Jan 06; Vol. 153, pp. e4. Date of Electronic Publication: 2025 Jan 06.